Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 2.942.772.742.942.97

What is the latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS is 2.94 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20252.94
Mar20242.77
Mar20232.74
Mar20222.94
Mar20212.97

How is Sales/Fixed Asset of GLENMARK PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 2.94
6.14
Mar2024 2.77
1.09
Mar2023 2.74
-6.80
Mar2022 2.94
-1.01
Mar2021 2.97 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,781.4 Cr 4% -0.5% 52.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,083.0 Cr -1% -7% -1% Stock Analytics
DIVIS LABORATORIES ₹163,971.0 Cr 5% -2.7% 15.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,660.0 Cr 3.2% -6.2% 29.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,686.0 Cr 2.3% -8.1% 13.5% Stock Analytics
CIPLA ₹99,086.7 Cr 0.9% -7.8% -12.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4%

-0.5%

52.2%

SENSEX

4.7%

-0.1%

3.6%


You may also like the below Video Courses